p19 INK4d (CDKN2D) Mouse Monoclonal Antibody [Clone ID: IMD-19]
CAT#: AM20657PU-N
p19 INK4d (CDKN2D) mouse monoclonal antibody, clone IMD-19, Purified
Product Images
Other products for "CDKN2D"
Specifications
Product Data | |
Clone Name | IMD-19 |
Applications | IF, IHC, IP, WB |
Recommended Dilution | Western Blot: 0.5-1 μg/ml. Immunocytochemistry. Immunohistochemistry on Paraffin Sections: 1-2 μg/ml. |
Reactivities | Human |
Host | Mouse |
Isotype | IgG1 |
Clonality | Monoclonal |
Immunogen | Recombinant Human p19INK4d. |
Specificity | This antibody recognizes Human p19INK4d and shows no cross reactivity with other proteins. |
Formulation | 1.2% Sodium Acetate State: Purified State: Lyophilized purified Ig fraction Stabilizer: 2 mg BSA Preservative: 0.01 mg Sodium Azide |
Reconstitution Method | Restore with 1.2% Sodium Acetate or neutral PBS |
Concentration | 0.1 mg/ml (after reconstitution with PBS) |
Purification | Affinity Chromatography |
Gene Name | Homo sapiens cyclin dependent kinase inhibitor 2D (CDKN2D), transcript variant 1 |
Database Link | |
Background | Cyclins are important in regulating the cell cycle through their formation of enzymatic complexes with various cyclin-dependent kinases. P19(INK4d) also kowns as cyclin-dependent kinase inhibitor 2D, is one of the novel members of the mouse INK4 gene family. Okuda et al. (1995) described the cloning of the human INK4d gene (CDKN2D). The predicted 166-amino acid protein is 86% identical to the mouse protein and about 45% identical to other human INK4 family members. |
Synonyms | p19-INK4d, p19, INK4D |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Cell cycle |
Documents
Product Manuals |
FAQs |
SDS |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.